Smith+Nephew’s advanced incision care products retain their extracellular matrix and native growth factors to give surgeons confidence when operating in high-stakes vascular environments.1
Explore clinical resources
Using BioTissue matrices for Vascular Surgery
- Natural extracellular matrix that’s stronger than amnion.1
- Has an adhesive barrier to protect delicate tissues during recovery.1
- Supports a faster, healthier recovery for a wide range of conditions.2-4
- Helps reduce the risk of complications.2-4
Clinical applications with BioTissue matrices
- Fasciotomy
- Venous leg ulcers (VLUs)
Smith+Nephew BioTissue portfolio
Our comprehensive BioTissue solutions support a range of specialties that require advanced incision care. See the full scope of application today.
STRAVIX PL◊
Lyopreserved Umbilical Tissue
GRAFIX XC◊
Cryopreserved Placental Membrane
GRAFIX XC PL◊
Lyopreserved Umbilical Tissue
OASIS
Matrix products
- Data on file at Osiris Therapeutics, Inc.
- Brandeisky J, Kurtz Phelan DH. Clinical outcome of Achilles tendon repair using viable intact cryopreserved umbilical tissue versus standard of care. Wounds. 2017; 29(11): E111-E114.
- Sundblad KW, Tassis EK. A quality improvement pilot assessment of the safety and associated.
- McGinness K, Kurtz Phelan DH. Use of viable cryopreserved umbilical tissue for so tissue defects in patients with gas gangrene: A case series. Wounds. 2018; 30(4): 90-95.